CONMED Corporation (CNMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CONMED Corporation (CNMD) has a cash flow conversion efficiency ratio of 0.013x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($13.47 Million) by net assets ($1.02 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CONMED Corporation (CNMD) balance sheet quality index to measure how much of total assets are equity-financed.
CONMED Corporation - Cash Flow Conversion Efficiency Trend (1990–2025)
This chart illustrates how CONMED Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CONMED Corporation cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CONMED Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CONMED Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sunac China Holdings Limited
F:SCNR
|
-0.097x |
|
Shenzhen Laibao High-Technology Co Ltd
SHE:002106
|
0.017x |
|
Jiangxi Guotai Civilian
SHG:603977
|
-0.035x |
|
Sivers IMA Holding AB
ST:SIVE
|
-0.016x |
|
Dongwon Ind
KO:006040
|
0.044x |
|
OceanFirst Financial Corp.
NASDAQ:OCFC
|
0.015x |
|
Ningbo Changhong Polymer Scientific & Technical Inc
SHG:605008
|
-0.082x |
|
Instalco Intressenter AB
ST:INSTAL
|
0.133x |
Annual Cash Flow Conversion Efficiency for CONMED Corporation (1990–2025)
The table below shows the annual cash flow conversion efficiency of CONMED Corporation from 1990 to 2025. For the full company profile with market capitalisation and key ratios, see CONMED Corporation stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.03 Billion | $170.69 Million | 0.165x | -4.74% |
| 2024-12-31 | $962.68 Million | $166.97 Million | 0.173x | +15.43% |
| 2023-12-31 | $834.22 Million | $125.35 Million | 0.150x | +235.75% |
| 2022-12-31 | $745.54 Million | $33.37 Million | 0.045x | -68.55% |
| 2021-12-31 | $785.43 Million | $111.77 Million | 0.142x | +56.36% |
| 2020-12-31 | $709.04 Million | $64.53 Million | 0.091x | -32.03% |
| 2019-12-31 | $710.47 Million | $95.13 Million | 0.134x | +18.71% |
| 2018-12-31 | $662.27 Million | $74.70 Million | 0.113x | +8.63% |
| 2017-12-31 | $631.43 Million | $65.57 Million | 0.104x | +57.72% |
| 2016-12-31 | $580.58 Million | $38.22 Million | 0.066x | -19.87% |
| 2015-12-31 | $585.07 Million | $48.07 Million | 0.082x | -26.72% |
| 2014-12-31 | $581.30 Million | $65.18 Million | 0.112x | -16.02% |
| 2013-12-31 | $606.32 Million | $80.95 Million | 0.134x | -14.87% |
| 2012-12-31 | $607.00 Million | $95.20 Million | 0.157x | -12.73% |
| 2011-12-31 | $573.07 Million | $102.99 Million | 0.180x | +175.65% |
| 2010-12-31 | $586.56 Million | $38.24 Million | 0.065x | +50.18% |
| 2009-12-31 | $576.51 Million | $25.03 Million | 0.043x | -62.25% |
| 2008-12-31 | $531.73 Million | $61.15 Million | 0.115x | -11.87% |
| 2007-12-31 | $505.00 Million | $65.89 Million | 0.130x | -11.02% |
| 2006-12-31 | $440.35 Million | $64.57 Million | 0.147x | +56.54% |
| 2005-12-31 | $453.01 Million | $42.43 Million | 0.094x | -43.93% |
| 2004-12-31 | $447.98 Million | $74.84 Million | 0.167x | +24.84% |
| 2003-12-31 | $433.49 Million | $58.01 Million | 0.134x | +15.27% |
| 2002-12-31 | $386.94 Million | $44.92 Million | 0.116x | -57.32% |
| 2001-12-31 | $283.63 Million | $77.15 Million | 0.272x | +74.48% |
| 2000-12-31 | $230.60 Million | $35.95 Million | 0.156x | -10.97% |
| 1999-12-31 | $211.30 Million | $37.00 Million | 0.175x | +51.93% |
| 1998-12-31 | $182.20 Million | $21.00 Million | 0.115x | -41.03% |
| 1997-12-31 | $162.70 Million | $31.80 Million | 0.195x | +19.69% |
| 1996-12-31 | $158.60 Million | $25.90 Million | 0.163x | +140.15% |
| 1995-12-31 | $75.00 Million | $5.10 Million | 0.068x | -64.69% |
| 1994-12-31 | $43.10 Million | $8.30 Million | 0.193x | +26.69% |
| 1993-12-31 | $37.50 Million | $5.70 Million | 0.152x | +63.40% |
| 1992-12-31 | $38.70 Million | $3.60 Million | 0.093x | +125.91% |
| 1991-12-31 | $34.00 Million | $1.40 Million | 0.041x | -89.86% |
| 1990-12-31 | $12.80 Million | $5.20 Million | 0.406x | -- |
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation an… Read more